Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Downgrade
Omega Healthcare downgraded to Underperform from Neutral at BofA » 06:33
10/27/21
10/27
06:33
10/27/21
06:33
OHI

Omega Healthcare

$29.81 /

-0.065 (-0.22%)

BofA analyst Joshua…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OHI Omega Healthcare
$29.81 /

-0.065 (-0.22%)

06:21 Today BofA
Omega Healthcare downgraded to Underperform from Neutral at BofA
10/08/21 Baird
Baird starts Omega Healthcare with Outperform, seen as market consolidator
10/07/21 Baird
Omega Healthcare initiated with an Outperform at Baird
09/24/21 Scotiabank
Omega Healthcare price target lowered to $35 from $37 at Scotiabank
OHI Omega Healthcare
$29.81 /

-0.065 (-0.22%)

Downgrade
Omega Healthcare downgraded to Underperform from Neutral at BofA » 06:21
10/27/21
10/27
06:21
10/27/21
06:21
OHI

Omega Healthcare

$29.81 /

-0.065 (-0.22%)

BofA analyst Joshua…

BofA analyst Joshua Dennerlein downgraded Omega Healthcare to Underperform from Neutral.

ShowHide Related Items >><<
OHI Omega Healthcare
$29.81 /

-0.065 (-0.22%)

10/08/21 Baird
Baird starts Omega Healthcare with Outperform, seen as market consolidator
10/07/21 Baird
Omega Healthcare initiated with an Outperform at Baird
09/24/21 Scotiabank
Omega Healthcare price target lowered to $35 from $37 at Scotiabank
08/26/21 BofA
Omega Healthcare downgraded to Neutral from Buy at BofA
OHI Omega Healthcare
$29.81 /

-0.065 (-0.22%)

Yesterday
Recommendations
Boston Properties sees FY21 FFO $6.50-$6.52, consensus $6.61 » 17:16
10/26/21
10/26
17:16
10/26/21
17:16
BXP

Boston Properties

$118.53 /

+1.44 (+1.23%)

Sees FY22 FFO…

Sees FY22 FFO $7.25-$7.45, consensus $7.26.

ShowHide Related Items >><<
BXP Boston Properties
$118.53 /

+1.44 (+1.23%)

BXP Boston Properties
$118.53 /

+1.44 (+1.23%)

09/01/21 Barclays
Boston Properties initiated with an Overweight at Barclays
09/01/21 Piper Sandler
Boston Properties price target raised to $140 from $135 at Piper Sandler
08/02/21 Argus
Boston Properties price target raised to $132 from $120 at Argus
07/14/21 Mizuho
Boston Properties assumed with a Neutral at Mizuho
BXP Boston Properties
$118.53 /

+1.44 (+1.23%)

BXP Boston Properties
$118.53 /

+1.44 (+1.23%)

Earnings
Boston Properties reports Q3 FFO $1.73, consensus $1.70 » 17:16
10/26/21
10/26
17:16
10/26/21
17:16
BXP

Boston Properties

$118.53 /

+1.44 (+1.23%)

Reports Q3 revenue…

Reports Q3 revenue $730.1M, consensus $708.74M.

ShowHide Related Items >><<
BXP Boston Properties
$118.53 /

+1.44 (+1.23%)

BXP Boston Properties
$118.53 /

+1.44 (+1.23%)

09/01/21 Barclays
Boston Properties initiated with an Overweight at Barclays
09/01/21 Piper Sandler
Boston Properties price target raised to $140 from $135 at Piper Sandler
08/02/21 Argus
Boston Properties price target raised to $132 from $120 at Argus
07/14/21 Mizuho
Boston Properties assumed with a Neutral at Mizuho
BXP Boston Properties
$118.53 /

+1.44 (+1.23%)

BXP Boston Properties
$118.53 /

+1.44 (+1.23%)

Earnings
UDR raises FY21 AFFO view to $1.82-$1.84 from $1.79-$1.83  16:19
10/26/21
10/26
16:19
10/26/21
16:19
UDR

UDR

$55.11 /

+0.45 (+0.82%)

Consensus $2.01.

ShowHide Related Items >><<
UDR UDR
$55.11 /

+0.45 (+0.82%)

UDR UDR
$55.11 /

+0.45 (+0.82%)

10/18/21 RBC Capital
UDR price target raised to $57 from $50 at RBC Capital
09/29/21 Mizuho
UDR price target raised to $58 from $54 at Mizuho
09/23/21 Goldman Sachs
UDR initiated with a Buy at Goldman Sachs
09/13/21 BTIG
UDR upgraded to Buy from Neutral at BTIG
UDR UDR
$55.11 /

+0.45 (+0.82%)

  • 31
    Mar
Earnings
UDR sees Q4 AFFO 46c-48c  16:18
10/26/21
10/26
16:18
10/26/21
16:18
UDR

UDR

$55.11 /

+0.45 (+0.82%)

 
ShowHide Related Items >><<
UDR UDR
$55.11 /

+0.45 (+0.82%)

UDR UDR
$55.11 /

+0.45 (+0.82%)

10/18/21 RBC Capital
UDR price target raised to $57 from $50 at RBC Capital
09/29/21 Mizuho
UDR price target raised to $58 from $54 at Mizuho
09/23/21 Goldman Sachs
UDR initiated with a Buy at Goldman Sachs
09/13/21 BTIG
UDR upgraded to Buy from Neutral at BTIG
UDR UDR
$55.11 /

+0.45 (+0.82%)

  • 31
    Mar
Earnings
UDR reports Q3 AFFO 46c, consensus 51c » 16:17
10/26/21
10/26
16:17
10/26/21
16:17
UDR

UDR

$55.11 /

+0.45 (+0.82%)

Reports Q3 revenue…

Reports Q3 revenue $329.77M, consensus $319.92M. "We once again achieved the high-end of our expectations across key performance metrics and raised guidance for the fourth time this year on the back of accretive capital allocation and strong operating results across our 21 markets, which have been further supplemented by our ongoing Platform innovations," said Tom Toomey, UDR's Chairman and CEO. "The competitive advantages created by our operational focus have and should continue to drive strong same-store growth and margin expansion as well as enable us to accretively deploy capital through numerous channels."

ShowHide Related Items >><<
UDR UDR
$55.11 /

+0.45 (+0.82%)

UDR UDR
$55.11 /

+0.45 (+0.82%)

10/18/21 RBC Capital
UDR price target raised to $57 from $50 at RBC Capital
09/29/21 Mizuho
UDR price target raised to $58 from $54 at Mizuho
09/23/21 Goldman Sachs
UDR initiated with a Buy at Goldman Sachs
09/13/21 BTIG
UDR upgraded to Buy from Neutral at BTIG
UDR UDR
$55.11 /

+0.45 (+0.82%)

  • 31
    Mar
Over a week ago
Hot Stocks
Pebblebrook Hotel acquires Avalon Bed & Breakfast, Duval Gardens for $20M » 16:17
10/20/21
10/20
16:17
10/20/21
16:17
PEB

Pebblebrook Hotel

$22.38 /

-0.46 (-2.01%)

Pebblebrook Hotel…

Pebblebrook Hotel announced that it acquired the 19-room Avalon Bed & Breakfast and 12-room Duval Gardens, both in Key West, Florida, for $20.0M. Based on the Company's initial investment in Avalon and Duval, it expects to generate a forward 12-month incremental annualized hotel net operating income, after a 4% capital reserve, of $1.6M to $2.4M.

ShowHide Related Items >><<
PEB Pebblebrook Hotel
$22.38 /

-0.46 (-2.01%)

PEB Pebblebrook Hotel
$22.38 /

-0.46 (-2.01%)

06/14/21 Evercore ISI
Pebblebrook Hotel upgraded to In Line from Underperform at Evercore ISI
03/12/21 BTIG
Pebblebrook Hotel price target raised to $27 from $23 at BTIG
03/01/21 Compass Point
Compass Point more bullish on hotels, upgrades Pebblebrook to Buy
03/01/21 Compass Point
Pebblebrook Hotel upgraded to Buy from Neutral at Compass Point
PEB Pebblebrook Hotel
$22.38 /

-0.46 (-2.01%)

Upgrade
Macerich upgraded to In Line from Underperform at Evercore ISI » 06:05
10/19/21
10/19
06:05
10/19/21
06:05
MAC

Macerich

$18.15 /

+0.46 (+2.60%)

Evercore ISI analyst…

Evercore ISI analyst Samir Khanal upgraded Macerich to In Line from Underperform with a price target of $18, up from $16. The analyst cites the improvement in foot traffic and sales the company has seen as part of the recovery for the upgrade. While Macerich's leverage still remains elevated in the A-mall category, the company has done a "lot of the heavy lifting" by raising more than $1B in equity via dispositions and the sale of common stock, Khanal tells investors in a research note. He sees little downside risk in the near to intermediate term for the shares.

ShowHide Related Items >><<
MAC Macerich
$18.15 /

+0.46 (+2.60%)

MAC Macerich
$18.15 /

+0.46 (+2.60%)

10/19/21 Evercore ISI
Macerich upgraded to In Line from Underperform at Evercore ISI
08/27/21 BTIG
Macerich price target lowered to $35 from $57 at BTIG
07/15/21 Jefferies
Macerich upgraded to Hold from Underperform at Jefferies
07/01/21 Citi
Macerich price target raised to $17 from $11 at Citi
MAC Macerich
$18.15 /

+0.46 (+2.60%)

MAC Macerich
$18.15 /

+0.46 (+2.60%)

Upgrade
Macerich upgraded to In Line from Underperform at Evercore ISI » 06:03
10/19/21
10/19
06:03
10/19/21
06:03
MAC

Macerich

$18.15 /

+0.46 (+2.60%)

Evercore ISI analyst…

Evercore ISI analyst Samir Khanal upgraded Macerich to In Line from Underperform.

ShowHide Related Items >><<
MAC Macerich
$18.15 /

+0.46 (+2.60%)

MAC Macerich
$18.15 /

+0.46 (+2.60%)

08/27/21 BTIG
Macerich price target lowered to $35 from $57 at BTIG
07/15/21 Jefferies
Macerich upgraded to Hold from Underperform at Jefferies
07/01/21 Citi
Macerich price target raised to $17 from $11 at Citi
06/28/21 Scotiabank
Macerich price target raised to $19 from $16 at Scotiabank
MAC Macerich
$18.15 /

+0.46 (+2.60%)

MAC Macerich
$18.15 /

+0.46 (+2.60%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.